Literature DB >> 23810639

Neurochemical abnormalities in unmedicated bipolar depression and mania: a 2D 1H MRS investigation.

Jun Xu1, Ulrike Dydak, Jaroslaw Harezlak, Jonathan Nixon, Mario Dzemidzic, Abigail D Gunn, Harish S Karne, Amit Anand.   

Abstract

The neurobiology and neurochemistry of bipolar disorder and its different phases are poorly understood. This study investigated metabolite abnormalities in both unmedicated bipolar depression as well as mania using 2D 1H magnetic resonance spectroscopy imaging (MRSI). MRSI data were obtained from 24 unmedicated bipolar disorder (BP) subjects (12 (hypo)manic (BPM)) and 12 depressed (BPD), and 20 closely matched healthy controls. 2D 1H MRSI data were collected from a 15-mm axial slice placed along the anterior commissure-posterior commissure (AC-PC) line to measure brain metabolites bilaterally in the thalamus and also the anterior and posterior cingulate cortex (ACC and PCC). Brain Lac/Cr levels were significantly increased in the BP group as a whole compared to healthy controls. Glutamate abnormalities varied across bipolar state as well as brain region: significantly increased Glx/Cr values were found in the left thalamus in BPD, but BPM had decreased Glu/Cr and Glx/Cr levels in the PCC when compared to healthy controls and decreased Glu/Cr levels even when compared to the BPD subjects group. The findings of the study point to state-related abnormalities of oxidative and glutamate metabolism in bipolar disorder.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Bipolar disorder; Depression; Glutamate; Lactate; MRS; Mania

Mesh:

Substances:

Year:  2013        PMID: 23810639      PMCID: PMC3729606          DOI: 10.1016/j.pscychresns.2013.02.008

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  44 in total

Review 1.  Anatomic and behavioral aspects of frontal-subcortical circuits.

Authors:  J L Cummings
Journal:  Ann N Y Acad Sci       Date:  1995-12-15       Impact factor: 5.691

Review 2.  A review of the possible relevance of inositol and the phosphatidylinositol second messenger system (PI-cycle) to psychiatric disorders--focus on magnetic resonance spectroscopy (MRS) studies.

Authors:  Hyeonjin Kim; Brent M McGrath; Peter H Silverstone
Journal:  Hum Psychopharmacol       Date:  2005-07       Impact factor: 1.672

3.  1H magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in bipolar disorder patients.

Authors:  Paolo Brambilla; Jeffrey A Stanley; Mark A Nicoletti; Roberto B Sassi; Alan G Mallinger; Ellen Frank; David Kupfer; Matcheri S Keshavan; Jair C Soares
Journal:  J Affect Disord       Date:  2005-05       Impact factor: 4.839

Review 4.  Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research.

Authors:  C Stork; P F Renshaw
Journal:  Mol Psychiatry       Date:  2005-10       Impact factor: 15.992

Review 5.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

Authors:  D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

6.  Measurement of brain phosphoinositide metabolism in bipolar patients using in vivo 31P-MRS.

Authors:  T Kato; T Shioiri; S Takahashi; T Inubushi
Journal:  J Affect Disord       Date:  1991-08       Impact factor: 4.839

7.  Decreased brain intracellular pH measured by 31P-MRS in bipolar disorder: a confirmation in drug-free patients and correlation with white matter hyperintensity.

Authors:  T Kato; J Murashita; A Kamiya; T Shioiri; N Kato; T Inubushi
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1998       Impact factor: 5.270

8.  31P magnetic resonance spectroscopy in the frontal lobe of major depressed patients.

Authors:  H P Volz; R Rzanny; S Riehemann; S May; H Hegewald; B Preussler; G Hübner; W A Kaiser; H Sauer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1998       Impact factor: 5.270

9.  Estimation of metabolite concentrations from localized in vivo proton NMR spectra.

Authors:  S W Provencher
Journal:  Magn Reson Med       Date:  1993-12       Impact factor: 4.668

10.  Lateralized abnormality of high energy phosphate metabolism in the frontal lobes of patients with bipolar disorder detected by phase-encoded 31P-MRS.

Authors:  T Kato; T Shioiri; J Murashita; H Hamakawa; Y Takahashi; T Inubushi; S Takahashi
Journal:  Psychol Med       Date:  1995-05       Impact factor: 7.723

View more
  18 in total

Review 1.  Metabolic Imaging in Humans.

Authors:  Taylor L Fuss; Leo L Cheng
Journal:  Top Magn Reson Imaging       Date:  2016-10

2.  Increased Brain Lactate During Depressive Episodes and Reversal Effects by Lithium Monotherapy in Drug-Naive Bipolar Disorder: A 3-T 1H-MRS Study.

Authors:  Rodrigo Machado-Vieira; Marcus V Zanetti; Maria C Otaduy; Rafael T De Sousa; Marcio G Soeiro-de-Souza; Alana C Costa; Andre F Carvalho; Claudia C Leite; Geraldo F Busatto; Carlos A Zarate; Wagner F Gattaz
Journal:  J Clin Psychopharmacol       Date:  2017-02       Impact factor: 3.153

3.  Vitamin D3 Supplemental Treatment for Mania in Youth with Bipolar Spectrum Disorders.

Authors:  Elif M Sikoglu; Ana A Liso Navarro; Debra Starr; Yael Dvir; Benjamin Udoka Nwosu; Suzanne M Czerniak; Ryan C Rogan; Martha C Castro; Richard A E Edden; Jean A Frazier; Constance M Moore
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-06       Impact factor: 2.576

4.  N-acetylaspartate normalization in bipolar depression after lamotrigine treatment.

Authors:  Paul E Croarkin; M Albert Thomas; John D Port; Joshua M Baruth; Doo-Sup Choi; Osama A Abulseoud; Mark A Frye
Journal:  Bipolar Disord       Date:  2014-12-12       Impact factor: 6.744

5.  Brain lactate and pH in schizophrenia and bipolar disorder: a systematic review of findings from magnetic resonance studies.

Authors:  Asli Ercan Dogan; Cagri Yuksel; Fei Du; Virginie-Anne Chouinard; Dost Öngür
Journal:  Neuropsychopharmacology       Date:  2018-03-14       Impact factor: 7.853

Review 6.  Metabotropic Glutamatergic Receptor 5 and Stress Disorders: Knowledge Gained From Receptor Imaging Studies.

Authors:  Irina Esterlis; Sophie E Holmes; Priya Sharma; John H Krystal; Christine DeLorenzo
Journal:  Biol Psychiatry       Date:  2017-09-19       Impact factor: 13.382

7.  Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression.

Authors:  E Haroon; C C Fleischer; J C Felger; X Chen; B J Woolwine; T Patel; X P Hu; A H Miller
Journal:  Mol Psychiatry       Date:  2016-01-12       Impact factor: 15.992

8.  Reduced density of glutamine synthetase immunoreactive astrocytes in different cortical areas in major depression but not in bipolar I disorder.

Authors:  Hans-Gert Bernstein; Gabriela Meyer-Lotz; Henrik Dobrowolny; Jana Bannier; Johann Steiner; Martin Walter; Bernhard Bogerts
Journal:  Front Cell Neurosci       Date:  2015-08-10       Impact factor: 5.505

Review 9.  Integrated neurobiology of bipolar disorder.

Authors:  Vladimir Maletic; Charles Raison
Journal:  Front Psychiatry       Date:  2014-08-25       Impact factor: 4.157

10.  Dorsal Anterior Cingulate Lactate and Glutathione Levels in Euthymic Bipolar I Disorder: 1H-MRS Study.

Authors:  Márcio Gerhardt Soeiro-de-Souza; Bruno F Pastorello; Cláudia da Costa Leite; Anke Henning; Ricardo A Moreno; Maria Concepción Garcia Otaduy
Journal:  Int J Neuropsychopharmacol       Date:  2016-08-12       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.